Cbay stock analysis

See CymaBay Therapeutics Inc. (CBAY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. CymaBay Therapeutics Inc (CBAY) Stock Analysis | Morningstar

CBAY | Complete CymaBay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Find the latest CymaBay Therapeutics Inc. (CBAY) stock quote, history, news and other vital information to help you with your stock trading and investing. Their forecasts range from $1.50 to $18.00. On average, they anticipate CymaBay Therapeutics' stock price to reach $5.81 in the next year. This suggests a  19 Mar 2020 Real-time trade and investing ideas on CymaBay Therapeutics Inc CBAY from the largest community of traders and investors. Get today's Cymabay Therapeu stock price and latest CBAY news as well as Cymabay Therapeu real-time stock quotes, technical analysis, full financials and   Stock Price Forecast for CBAY: Cymabay Therapeutics Inc holds several positive signals, but we still don't find these to be enough for a buy candidate.

View today's stock price, news and analysis for CymaBay Therapeutics Inc. (CBAY). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

13 Dec 2019 CymaBay Therapeutics, Inc. - CBAY Stock Chart Technical Analysis for 12-13- 2019 Subscribe to My MAIN Channel Here:  CBAY / Cymabay Therapeutics, Chief Executive Officer, Director, 120,000. Does this Insider's Trades Predict Future Stock Performance? The following charts The stock performance is charted as cumulative percent change in share price. 4 days ago The stock's price range for the 52-week period managed to maintain the performance between $1.21 and $13.89. The company's shares,  10 Mar 2020 Shares of CymaBay Therapeutics, Inc. (NASDAQ: CBAY) declined from pricing analysis and a holistic overview of the market situations in the  Cymabay Therapeutics Inc (CBAY) Market Cap, 133.965 Million, Shares Outstanding, 68.7 Million, Avg Volume, 1.572 Check out our reporting and analysis. 20 Nov 2007 The price per share at which these new ordinary shares will be issued will be based on the average closing price per share during the 90-day 

Cymabay Therapeutics Inc. (CBAY) Stock Chart

Nov 05, 2019 · Cymabay Therapeutics, Inc. focuses on developing therapies to treat metabolic diseases. Its lead product candidate is Arhalofenate, which completed … CymaBay Therapeutics Inc. - CBAY - Stock Price & News ...

Nov 07, 2019 · CBAY, Cymabay Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CymaBay Therapeutics Inc. Common Stock (CBAY) Real-Time ... CBAY's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low

CymaBay Therapeutics, Inc. - CBAY Stock Chart Technical ...

Cymabay Therapeutics stock forecast, CBAY price prediction: Buy or sell Cymabay Therapeutics, Inc shares? by Gov Capital. CBAY Price is 1.405 USD today. 1  Learn about CBAY with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a Stock Style. Large-Cap  View today's stock price, news and analysis for CymaBay Therapeutics Inc. ( CBAY). Barron's also provides information on historical stock ratings, target prices,  In depth view into CBAY (CymaBay Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.

Learn about CBAY with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a Stock Style. Large-Cap  View today's stock price, news and analysis for CymaBay Therapeutics Inc. ( CBAY). Barron's also provides information on historical stock ratings, target prices,  In depth view into CBAY (CymaBay Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. 17 Mar 2020 CBAY stock price has been found in the range of $1.3809 to $1.525. If compared to the average trading volume of 1.48M shares, CBAY reached a  CBAY stock rating and analysis - CymaBay Therapeutics : a summary of key financial strength and profitability metrics. CymaBay (NASDAQ: CBAY) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on